BusinessGalectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congress™ 2017By Nasdaq OMXApr 18, 2017, 12:01 PM UTC
BusinessGalectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congress™ 2017By Nasdaq OMXApr 18, 2017, 12:01 PM UTC
BusinessGalectin Therapeutics Issues Statement Regarding GALTW and GALTUBy Nasdaq OMXMar 23, 2017, 12:30 PM UTC
BusinessGalectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development of Novel Therapies for Nonalcoholic SteatohepatitisBy Nasdaq OMXOct 7, 2016, 12:30 PM UTC
BusinessGalectin Therapeutics Announces Results From 12-Week Extension of Phase 2a Psoriasis Clinical TrialBy Nasdaq OMXAug 25, 2016, 12:00 PM UTC
